BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Inflammatory bowel diseases
1
Duodenal Crohn's disease: Case report and systematic review
3/7/2024 9:32:28 AM | Browse: 189 | Download: 429
2
Cardiovascular implications of inflammatory bowel disease: An updated review
11/23/2023 8:41:50 AM | Browse: 233 | Download: 543
3
Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
6/16/2023 9:52:18 AM | Browse: 290 | Download: 888
4
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
1/20/2023 1:48:20 PM | Browse: 345 | Download: 714
5
Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
1/6/2023 2:52:58 AM | Browse: 329 | Download: 752
6
Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
12/27/2022 10:06:45 AM | Browse: 337 | Download: 795
7
Evaluation of gut dysbiosis using serum and fecal bile acid profiles
12/2/2022 12:50:19 PM | Browse: 350 | Download: 670
8
Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
9/27/2022 1:00:17 PM | Browse: 510 | Download: 1266
9
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
9/23/2022 9:45:22 AM | Browse: 477 | Download: 1084
10
Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
8/10/2022 8:23:14 AM | Browse: 605 | Download: 1636
11
Shared decision-making in the management of patients with inflammatory bowel disease
7/13/2022 7:30:59 AM | Browse: 453 | Download: 945
12
Novel drug delivery systems for inflammatory bowel disease
5/12/2022 8:42:29 AM | Browse: 545 | Download: 1163
13
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
3/30/2022 3:20:26 PM | Browse: 527 | Download: 937
14
“Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease”: A letter to the editor
2/24/2022 9:46:00 AM | Browse: 527 | Download: 857
15
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 624 | Download: 1329
16
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
12/27/2021 5:24:00 AM | Browse: 498 | Download: 963
17
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
12/10/2021 9:08:48 AM | Browse: 550 | Download: 1319
18
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor
12/10/2021 9:08:48 AM | Browse: 540 | Download: 897
19
Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease
9/3/2021 8:21:31 AM | Browse: 591 | Download: 1246
20
Viral infections in inflammatory bowel disease: Tips and tricks for correct management
7/19/2021 2:10:40 PM | Browse: 559 | Download: 1331
21
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil
6/18/2021 5:06:16 AM | Browse: 673 | Download: 2046
22
Receptor for advanced glycation end-products axis and COVID-19 in inflammatory bowel diseases: A dangerous liaison?
5/13/2021 10:05:39 AM | Browse: 528 | Download: 1108
23
Risk stratification and geographical mapping of Brazilian inflammatory bowel diseases patients during COVID-19 outbreak: Results from a nationwide survey
3/25/2021 11:42:15 AM | Browse: 682 | Download: 1849
24
Helicobacter pylori: Commensal, symbiont or pathogen?
2/20/2021 2:51:13 AM | Browse: 893 | Download: 1646
25
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores
12/13/2020 7:01:09 AM | Browse: 797 | Download: 1766
26
Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review
9/22/2020 3:17:13 AM | Browse: 795 | Download: 1942
27
Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection
6/21/2020 2:15:44 PM | Browse: 960 | Download: 1660
28
Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status
6/8/2020 3:14:59 AM | Browse: 839 | Download: 1440
29
Increased circulating circular RNA_103516 is a novel biomarker for adult inflammatory bowel disease
11/7/2019 1:35:59 AM | Browse: 868 | Download: 2314
30
Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases
9/25/2019 3:03:24 AM | Browse: 857 | Download: 1388
31
Role of NLRP3 inflammasome in inflammatory bowel diseases
9/7/2019 4:43:36 AM | Browse: 887 | Download: 1381
32
Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment
8/21/2019 9:19:18 AM | Browse: 992 | Download: 1707
33
Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
8/14/2019 1:31:33 PM | Browse: 831 | Download: 1931
34
Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
8/14/2019 1:31:33 PM | Browse: 986 | Download: 1488
35
Bone alterations in inflammatory bowel diseases
8/6/2019 11:50:46 AM | Browse: 1080 | Download: 1436
36
Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
6/14/2019 9:31:26 AM | Browse: 913 | Download: 1288
37
Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review
3/7/2019 5:00:17 AM | Browse: 1109 | Download: 1639
38
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
3/7/2019 3:51:24 AM | Browse: 1160 | Download: 1668
39
Vitamin D therapy in children with inflammatory bowel disease: A systematic review
1/22/2019 9:48:23 AM | Browse: 1031 | Download: 1562
40
Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
10/12/2018 5:32:21 AM | Browse: 1194 | Download: 1831
41
Web-based learning in inflammatory bowel diseases: General truths and current specifics
9/28/2018 10:31:14 AM | Browse: 1026 | Download: 1472
42
From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting
9/6/2018 1:33:44 AM | Browse: 1063 | Download: 1848
43
Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models
5/6/2018 1:12:00 PM | Browse: 1210 | Download: 1528
44
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study
10/21/2017 7:10:38 AM | Browse: 963 | Download: 1918
45
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
9/25/2017 8:56:57 AM | Browse: 1166 | Download: 2005
46
Helminths as an alternative therapy for intestinal diseases
9/7/2017 8:51:55 AM | Browse: 1276 | Download: 1861
47
Prognostic significance of red blood cell distribution width in gastrointestinal disorders
7/20/2017 10:12:50 AM | Browse: 1447 | Download: 1788
48
P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers
3/6/2017 1:27:00 PM | Browse: 1142 | Download: 1914
49
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
12/19/2016 8:28:00 PM | Browse: 1325 | Download: 1827
50
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
12/13/2016 12:40:00 AM | Browse: 1466 | Download: 2001
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345